0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence |

Stenting or Not Stenting Before Operating Malignant Colonic Obstruction? That Is the Question—Reply

Hester Y. S. Cheung, FRACS; Cliff C. C. Chung, FRCSEd; Michael K. W. Li, FRCS, FRCSEd
Arch Surg. 2010;145(6):601-602. doi:10.1001/archsurg.2010.87.
Text Size: A A A
Published online

Extract

In reply

We greatly appreciate Slim and colleagues' interest in our article.1 We also congratulate them on their multicenter randomized controlled trial. They rightly pointed out that there may be possible tumor dissemination following colonic stenting in theory, but there are no oncological consequences reported in the literature so far.2 On the other hand, systemic reviews have demonstrated the safety and efficacy of endoluminal stenting for patients with colorectal cancer, with low stent-related mortality of less than 1%. The median perforation and stent migration rates were only 4% and 11%,3 respectively.4 In our earlier reported series, in which colonic stenting was used in 68 patients with distal colorectal tumors from February 2002 to August 2008—including emergency stenting in 53 patients with acute intestinal obstruction, palliative stenting for endoscopically obstructed cancer in 12 patients, as well as preemptive stenting in 3 patients with locally advanced stenotic rectal cancer intended for neoadjuvant chemoirradiation—the technical success and clinical success rates were 81% and 65%, respectively.5 Our experience showed that colonic stenting is a useful adjunct in the management of distal colorectal cancer. Apart from being an alternative measure for palliation, it is an effective and noninvasive way for relieving obstruction in patients with obstructed tumors, allowing them to undergo subsequent 1-stage laparoscopic tumor resection. It is also useful in patients with locally advanced rectal cancer, in whom neoadjuvant chemoirradiation is planned. Nonetheless, as the current evidence on the benefits of colonic stenting as a bridge to surgery in patients with malignant colonic obstruction is inconclusive because of methodological weakness in the trials or small sample size,3 a properly conducted multicenter randomized controlled trial with a larger sample size and longer follow-up is warranted to establish its role and to investigate the long-term oncological outcomes of this approach.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

June 1, 2010
Karem Slim, MD; Isabelle Pirlet, MD; Bertrand Millat, MD, PhD
Arch Surg. 2010;145(6):601. doi:10.1001/archsurg.2010.86.
CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
brightcove.createExperiences();